If you need more lookups,
subscriptions start at $34 USD/month.
Robert Garabedian Location
United States
Robert Garabedian Work
Director of Engineering @ (September 2025 - Present)
Founder @ RG Engineering (March 2024 - Present)
Vice President Research and Manufacturing @ (September 2023 - February 2024)
Head of R and D @ Devoro Medical now Boston Scientific (March 2017 - August 2023)
VP of R and D, QA and OPs @ Three Rivers Medical (March 2015 - March 2017)
Sr Director of Research and Development @ (February 2013 - November 2014)
Director of Research and Development @ (November 2007 - February 2013)
Director of Research and development @ Barrx Medical (November 2005 - November 2007)
Principal Engineer Target Therapeutics Division @ (June 2003 - November 2005)
Principal Engineer Oncology Division @ (January 1999 - June 2003)
Research and Development Engineer Medi-Tech Devision @ (May 1993 - January 1999)
Robert Garabedian Education
University of Massachusetts at Lowell
BS (Mechanical Engineering)
1987-1991
Robert Garabedian Skills
Medical Devices
Design Control
FDA
Experience with Catheter Development
Spine
RF Ablation
Braiding
Commercialization
Biomedical Engineering
Catheters
Capital Equipment
ISO 13485
Product Launch
Surgical Instruments
R&D
Cardiology
CAPA
Market Development
Research
Business Development
Java
Development
Management
Robert Garabedian Summary
Robert Garabedian, based in United States, is currently a Director of Engineering at Swan EndoSurgical Inc.. Robert Garabedian brings experience from previous roles at RG Engineering, MedLumics, S.L., Devoro Medical now Boston Scientific and Three Rivers Medical. Robert Garabedian holds a 1987 - 1991 BS in Mechanical Engineering @ University of Massachusetts at Lowell. With a robust skill set that includes Medical Devices, Design Control, FDA, Experience with Catheter Development, Spine and more. Robert Garabedian has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Robert Garabedian?
Find contact details for 700 million professionals.